The Role of Histone Deacetylase Inhibitors in Uveal Melanoma: Current Evidence

Volume: 38, Issue: 7, Pages: 3817 - 3824
Published: Jul 1, 2018
Abstract
Uveal melanoma is the most common intraocular malignancy in adults, representing approximately 3% of all melanoma cases. Despite progress in chemotherapy, radiation and surgical treatment options, the prognosis and survival rates remain poor. Acetylation of histone proteins causes transcription of genes involved in cell growth, DNA replication and progression of cell cycle. Overexpression of histone deacetylases occurs in a wide spectrum of...
Paper Details
Title
The Role of Histone Deacetylase Inhibitors in Uveal Melanoma: Current Evidence
Published Date
Jul 1, 2018
Volume
38
Issue
7
Pages
3817 - 3824
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.